Ozanimod
Ozanimod (RPC1063) is a specific oral S1P Receptor 1 modulator. Ozanimod has been used in trials studying the treatment of Crohn’s Disease, Ulcerative Colitis, Multiple Sclerosis, and Relapsing Multiple Sclerosis.
| Catalog Number | T6923 |
| Alternative Name(s) | RPC-1063 |
| Research Area | GPCR/G Protein |
| Molecular Formula | C23H24N4O3 |
| CAS# | 1306760-87-1 |
| Purity | 99.74% |
| SMILES | C(#N)c1c(ccc(c1)c1onc(n1)c1c2CC[C@@H](c2ccc1)NCCO)OC(C)C |
| Size | 50 mg |
| Supplier Page | https://www.targetmol.com/compound/Ozanimod |
| Additional Information | https://www.targetmol.com/datasheet/T6923 |